| Ticker | LABB |
|---|---|
| ISIN | MX01LA010006 |
| Sector | Atención sanitaria |
| Industria | Drug Manufacturers - Specialty & Generic |
| Mercado | BMV |
| Capitalización | $16,048,103,136 |
| Beta | 0.29 |
| Último dividendo | US$ 0,8000 |
| Sitio web | https://www.genommalab.com |
| CEO | Juan Marco Sparvieri |
| Fecha de IPO | 18/06/2008 |
| País | MX |
| Dirección | Av. Antonio Dovalí Jaime no.70, Mexico City, DF, 01210 |
| Volumen | 3,244,970 |
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. It provides skin care, health and wellness, hair care, pain relief, cough and cold, gastro, sexual health, antiperspirant deodorant, hand sanitizer, isotonic deink, and razor products, as well as analgesics, antifungals, and hemorrhoids. The company offers its products under the C...
El precio actual de Genomma Lab Internacional (LABB) es de 16.48, con una variación del 1.17%.
Genomma Lab Internacional opera en el sector Healthcare, industria Drug Manufacturers - Specialty & Generic.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones